Peter Diamandis

Rank 8 of 47

Score 139

Within just 6 MONTHS the therapy was created, tested and approved, showing the drastic potential for rapid, on-demand development of genetic therapies for our critically ill patients.

6/3/2025, 8:01:43 PM

In reply to:

Peter H. Diamandis, MD

@PeterDiamandis

10d

Doctors created a custom-designed gene-editing CRSPR based treatment that was delivered directly into his body, especially tailored for his UNIQUE genetic sequence: a shift towards precision medicine for rare diseases.

Peter H. Diamandis, MD

@PeterDiamandis

10d

KJ Muldoon (7 months old) was diagnosed with CPS1 deficiency (a disorder where the liver can't break down ammonia, leading to death), with the only known cure being a liver transplant, an extremely challenging and unfeasible solution.

Peter H. Diamandis, MD

@PeterDiamandis

10d

Personalized gene Editing will save YOU next.

We have a WORKING again a proof-of-concept for personalized gene-editing. An infant received the first in vivo CRISPR gene-edited therapy for a CPS1 deficiency.

This is HUGE, here's the breakthrough of this case:

The statement highlights the rapid development and approval of a genetic therapy, emphasizing the potential for quick advancements in medical treatments for critically ill patients. It aligns with the promotion of scientific progress and innovation in healthcare.

Principle 1:
I will strive to do no harm with my words and actions.
The statement promotes a positive development in healthcare, potentially reducing harm by offering new treatment options. [+2]
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.
It fosters understanding and appreciation for advancements in genetic therapies, promoting empathy for patients with rare diseases. [+2]
Principle 6:
I will use my influence for the betterment of society.
The statement uses its platform to highlight a significant medical advancement, contributing to societal betterment. [+2]